Why NovoCure Stock Skyrocketed 152% in 2019
Shares of NovoCure (NASDAQ: NVCR), which makes devices for treating cancerous solid tumors with electric fields, rocketed 152% higher last year, according to data from S&P Global Market Intelligence.
That sizzling performance makes it one of last year's hottest healthcare stocks. For context, the S&P 500 returned 31.5% in 2019.
NovoCure's Optune. Image source: NovoCure.
Source Fool.com